By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Novan Therapeutics 

4222 Emperor Boulevard
Suite 200
Durham  North Carolina  27703  U.S.A.
Phone: 919-485-8080 Fax: n/a



Company News
Novan Therapeutics Announces First Patient Dosed In Phase 3 Program For SB204 2/23/2016 7:37:07 AM
Novan Therapeutics Announces Robert A. Ingram As Chairman 2/8/2016 8:06:06 AM
Novan Therapeutics Receives $30 Million in New Financing, Remains Mum on Plans 12/22/2015 7:14:49 AM
Novan Therapeutics to Build New Manufacturing Site for its Experimental Acne Treatments 10/28/2015 6:51:25 AM
Novan Therapeutics Appoints Chief Financial Officer And Chief Commercial Officer To Leadership Team 10/7/2015 7:36:37 AM
Novan Therapeutics Announces Successful Phase IIb Clinical Trial Results With SB204 For The Treatment Of Acne Vulgaris 9/29/2015 5:56:15 AM
Novan Therapeutics Adds Clinical Exposure And Safety Data To SB204 Acne Program 6/10/2015 8:50:41 AM
Novan Therapeutics Secures $50 Million Private Financing; Funds Intended to Advance SB204 into Phase 3 3/30/2015 10:43:50 AM
Led By Ex-Elan (ELN) Execs, Malin Rakes in $350 Million and Looks to Invest in Viamet, Novan Therapeutics 3/25/2015 6:27:34 AM
Novan Therapeutics Achieves Target Enrollment For Phase 2 Acne Study 3/18/2015 10:17:59 AM